World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
15020
World Ranking
16959
National Ranking
6989

Alexander J. Muller publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Alexander J. Muller sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 210 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Alexander J. Muller D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alexander J. Muller sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Alexander J. Muller is affiliated with the Lankenau Institute for Medical Research in the United States. Their research spans multiple areas within immunology, microbiology, medicine, and neuroscience, with a particular focus on immune mechanisms and their implications for cancer and brain disorders.

Their work addresses various interconnected topics including:

  • Tryptophan and brain disorders
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Stress Responses and Cortisol

Their publication record shows contributions primarily in the fields of immunology and oncology with notable frequent venues such as:

  • Cancer Research
  • The Journal of Immunology
  • Frontiers in Immunology
  • Journal for ImmunoTherapy of Cancer
  • Cancer Immunology Research

Alexander J. Muller's recent scientific papers include:

  • "Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses," 2020, Frontiers in Immunology
  • "Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses," 2020, Journal for ImmunoTherapy of Cancer
  • "IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization," 2021, Cancer Immunology Research
  • "Heartbeat Classification by Random Forest With a Novel Context Feature: A Segment Label," 2022, IEEE Journal of Translational Engineering in Health and Medicine
  • "IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation," 2023, Frontiers in Oncology

Frequent collaborators reflect a network of researchers engaged in related areas, including:

  • James B. DuHadaway
  • George C. Prendergast
  • Souvik Dey
  • Erika Sutanto-Ward
  • Laura Mandik-Nayak

The subfields addressed in their work highlight a strong concentration in:

  • Immunology
  • Biological Psychiatry
  • Oncology
  • Molecular Biology
  • Neurology

Alexander J. Muller's body of work illustrates an interdisciplinary approach combining immunology, oncology, and neuroscience. This approach focuses on the role of immune cells and signaling pathways such as IDO1 in the modulation of inflammatory and neovascular processes relevant to tumor biology and brain disorders.

Best Publications

  • Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

    Tracy G. Lugo;Ann-Marie Pendergast;Alexander J. Muller;Owen N. Witte

  • Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

    Alexander J Muller;James B DuHadaway;P Scott Donover;Erika Sutanto-Ward

  • Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses

    De Yan Hou;Alexander J. Muller;Madhav D. Sharma;James DuHadaway

  • Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

    Richard Metz;James B. DuHadaway;Uma Kamasani;Lisa Laury-Kleintop

  • Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance

    Winfried Hinrichs;Caroline Kisker;Martina Düvel;Alexander Müller

  • BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

    A J Muller;J C Young;A M Pendergast;M Pondel

  • Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

    Jessica B. Katz;Alexander J. Muller;Alexander J. Muller;George C. Prendergast;George C. Prendergast

  • Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer

    George C. Prendergast;George C. Prendergast;Courtney Smith;Sunil Thomas;Laura Mandik-Nayak

  • Discovery of IDO1 Inhibitors: From Bench to Bedside

    George C. Prendergast;William P. Malachowski;James B. DuHadaway;Alexander J. Muller

  • BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner

    Ann Marie Pendergast;Alexander J. Muller;Marie H. Havlik;Yoshiro Maru

  • Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors

    Alexander J. Muller;Peggy A. Scherle

  • The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists

    Sunil Thomas;Jacques Izard;Emily Walsh;Kristen Batich

  • IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development

    Courtney Smith;Mee Young Chang;Katherine H. Parker;Daniel W. Beury

  • Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase

    Alexander J. Muller;Madhav D. Sharma;Phillip R. Chandler;James B. DuHadaway

  • Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.

    George C. Prendergast;George C. Prendergast;William Paul Malachowski;Arpita Mondal;Peggy Scherle

  • Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

    Alexander J Muller;Mark G Manfredi;Yousef Zakharia;George C Prendergast

  • Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.

    Paul Gaspari;Tinku Banerjee;William P. Malachowski;Alexander J. Muller

  • A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

    T Banerjee;J B DuHadaway;P Gaspari;E Sutanto-Ward

  • Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer

    Alexander J Muller;George C Prendergast

  • Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

    Sanjeev Kumar;William P. Malachowski;James B. DuHadaway;Judith M. LaLonde

Frequent Co-Authors

George C. Prendergast
George C. Prendergast Lankenau Institute for Medical Research
Owen N. Witte
Owen N. Witte University of California, Los Angeles
Ann Marie Pendergast
Ann Marie Pendergast Duke University
Andrew L. Mellor
Andrew L. Mellor Newcastle University
David H. Munn
David H. Munn Augusta University
Suzanne Ostrand-Rosenberg
Suzanne Ostrand-Rosenberg University of Maryland, Baltimore County
Charles J. Yeo
Charles J. Yeo Thomas Jefferson University
Jonathan R. Brody
Jonathan R. Brody Thomas Jefferson University
Peggy Scherle
Peggy Scherle Incyte (United States)
Arnold J. Levine
Arnold J. Levine Institute for Advanced Study

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Biology or Biochemistry opens doors to several advanced fields and online programs. Many students look to expand their qualifications or pivot toward healthcare leadership by considering cahme-accredited online mha programs. These degrees focus on healthcare administration, blending science knowledge with management skills.

Those interested in nursing can pursue a terminal nursing degree online. Choose from top options like a dnp program no clinical, which allows you to advance your expertise without the need for onsite clinical practicums.

If you’re passionate about influencing policy or leading large teams, there are cutting-edge doctoral programs for healthcare administration. These programs focus on executive leadership and strategic decision-making in the healthcare sector.

For those aiming for a specialized clinical role, online pharmacy programs provide flexible pathways to earn a doctorate in pharmacy. This can lead to diverse opportunities in research, clinical practice, and pharmaceutical industries.

Best Scientists Citing Alexander J. Muller

Trending Scientists

Recently Published Articles